Breaking News
Which party represents Americans?
Even The Best AI Scenario Is The End Of Everything We've Ever Been
In Simulated War Games, Top AI Models Recommended Using Nukes 95% Of The Time
Rising Cancer Rates, the Globalist Agenda, and the Big Business Land Grab Making You Poor
Top Tech News
New Spray-on Powder Instantly Seals Life-Threatening Wounds in Battle or During Disasters
AI-enhanced stethoscope excels at listening to our hearts
Flame-treated sunscreen keeps the zinc but cuts the smeary white look
Display hub adds three more screens powered through single USB port
We Finally Know How Fast The Tesla Semi Will Charge: Very, Very Fast
Drone-launching underwater drone hitches a ride on ship and sub hulls
Humanoid Robots Get "Brains" As Dual-Use Fears Mount
SpaceX Authorized to Increase High Speed Internet Download Speeds 5X Through 2026
Space AI is the Key to the Technological Singularity
Velocitor X-1 eVTOL could be beating the traffic in just a year
FDA Gives Emergency Authorization of Hydroxychloroquine Use
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the "off-label" drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.